FONAR Corp.

  • Market Cap: Micro Cap
  • Industry: Miscellaneous
  • ISIN: US3444374058
USD
14.64
0.25 (1.77%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About FONAR Corp. stock-summary
stock-summary
FONAR Corp.
Miscellaneous
Fonar Corporation (Fonar) is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilizes MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions and injuries. The Company operates its business through two segments: Medical Equipment segment, and Physician Management and Diagnostic Services segment. Its Medical Equipment segment is conducted through Fonar. Its Physician Management and Diagnostic Services segment is conducted through its subsidiary Health Management Company of America (HMCA). It offers Upright MRI, which is used to scan any part of the body. The Upright MRI allows patients to be scanned in various conditions, such as standing, sitting, bending or lying down in any position. The Company offers SMART, where scanning allows for same-scan customization of 63 slices.
Company Coordinates stock-summary
Company Details
110 Marcus Dr , MELVILLE NY : 11747-4228
stock-summary
Tel: 1 631 6942929
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 10 Schemes (16.12%)

Foreign Institutions

Held by 18 Foreign Institutions (3.17%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Dr. Raymond Damadian
Chairman of the Board, Principal Financial Officer, Treasurer
Mrs. Claudette Chan
Secretary, Director
Mr. Ronald Lehman
Independent Director
Mr. Charles O'Data
Independent Director
Richard Turk
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
27 Million
(Quarterly Results - Mar 2025)
Net Profit:
3 Million
stock-summary
Industry

Miscellaneous

stock-summary
Market cap

USD 99 Million (Micro Cap)

stock-summary
P/E

8.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.30

stock-summary
Return on Equity

6.38%

stock-summary
Price to Book

0.57